Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning Saal-Bulas syndrome
Updated Dec 8, 2025
FDA approves Omisirge (omidubicel-onlv), the first cellular therapy for severe aplastic anemia, marking a significant advancement in treatment options for this condition. This approval highlights the potential of hematopoietic stem cell transplants in addressing severe cases of SAA.